Living PlatformTSE:7091 +0.08%67 EBITDA Margin % is 4.41% as of Mar. 2026, which is 14% below its 10-year median of 5.14. GuruFocus rates TSE:7091 with a GF Score™ of 67/100 and a GF Value™ of 円1,403.21 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Living Platform ranks worse than 64.07% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Living Platform's EBITDA for the
six
months ended in Mar. 2026 was 円497 Mil. Living Platform's Revenue for the
six
months ended in Mar. 2026 was 円11,274 Mil. Therefore, Living Platform's EBITDA margin for the quarter that ended in Mar. 2026 was 4.41%.
Living Platform (TSE:7091) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Living Platform EBITDA Margin % Related Terms
Living Platform EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Living Platform's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7091 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Living Platform's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Living Platform EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Living Platform's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Living Platform's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Living Platform (TSE:7091) has a EBITDA Margin % of 4.41% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Living Platform and its competitors. This is 14% below median its historical median of 5.14. Over the past decade, Living Platform's EBITDA Margin % has ranged from 4.61 to 8.75. According to the industry distribution chart, Living Platform ranks #428 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 64.1%.
Is Living Platform's EBITDA Margin % too high?
Living Platform's current EBITDA Margin % of 4.41% is 14% below median its 10-year median of 5.14. Over the past 10 years, this metric has ranged from a low of 4.61 to a high of 8.75. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Living Platform's value of 4.41% is 56.8% below this industry median. Based on the distribution chart, Living Platform ranks #428 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Living Platform has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Living Platform's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Living Platform ranks #428 out of 668 companies for EBITDA Margin %. This places Living Platform in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Living Platform's value of 4.41% is 56.8% below this benchmark. Historically, Living Platform's own EBITDA Margin % has ranged from 4.61 to 8.75 over the past decade. While the company's 10-year median is 5.14 vs. the industry median of 10.21, Living Platform has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Living Platform's current EBITDA Margin % of 4.41% is 56.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Living Platform and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Living Platform's current EBITDA Margin % is 4.41%, which is 14% below median its own 10-year median of 5.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Living Platform stock overvalued right now?
Based on GuruFocus' analysis, Living Platform (TSE:7091) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,403.21, compared to a current price of 円1,199.00 — trading 14.6% below its estimated fair value. The current EBITDA Margin % is 4.41%, which is 14% below median its 10-year median of 5.14 and 56.8% below the Healthcare Providers & Services industry median of 10.21. Living Platform's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Living Platform (TSE:7091), the current EBITDA Margin % is 4.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Living Platform (TSE:7091) Overvalued in 2026?
Based on GuruFocus' analysis, Living Platform stock appears to be undervalued.
The current stock price of 円1,199.00 is trading 14.6% below its estimated GF Value™ of 円1,403.21.
GuruFocus considers Living Platform to be Modestly Undervalued.
Key valuation signals for TSE:7091:
EBITDA Margin %: 4.41% (14% below median its 10-year median of 5.14)
GF Value™: 円1,403.21 vs. price of 円1,199.00 (14.6% below fair value)
Industry Position: 56.8% below the Healthcare Providers & Services median (#428 of 668)
No single metric tells the full story. See the TSE:7091 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Living Platform Ltd is engaged in providing nursing care, childcare, and support for people with disabilities. The company's services include paid nursing home care, Elderly housing with service, Visiting care, Regular patrol, ad hoc care nurs, ing care, Home-visit nursing, Home care support, Small multifunctional home care, among others. The Group operates in a single segment, the Life Care Business.
67GF Score
Get the complete analysis for TSE:7091
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7091 has been successfully added to your 
